Terumo Acquires 5% Of Fuji Pharma To Grow Drug/Device Combo Product Business
This article was originally published in The Pink Sheet Daily
Executive Summary
Partners hope to capitalize on reform that narrows approval of pre-filled syringes to a single agency.
You may also be interested in...
Terumo To Expand Cerebral Aneurysm Device Sales In The U.S., Other Markets
TOKYO - Terumo plans to expand its product line of cerebral aneurysm and other brain treatment devices in the U.S. and overseas markets with hopes of reaching ¥10 billion ($992 million) in cerebral aneurism device sales by March 2011, Terumo said Sept. 3
More Reform Eyed For Japan's OTC Deregulation
Japan's executive branch will urge the country's drug regulators to relax recently imposed limits on online sales of OTC products
More Reform Eyed For Japan's OTC Deregulation
Japan's executive branch will urge the country's drug regulators to relax recently imposed limits on online sales of OTC products